4942Safety evaluation of certain food additives: prepared by the ninety-second meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA)Publications · 26 mai 2022
4943Safety evaluation of certain food additives: prepared by the eighty-ninth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA)Publications · 26 mai 2022
4944Recommandations de l'OMS concernant les soins maternels et néonataux pour une expérience positive de la période postnatale : résumé analytiquePublications · 26 mai 2022
4945WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia: web annex A: a systematic review on the treatment of visceral leishmaniasis in HIV-Leishmania co-infected persons in East Africa and South-East AsiaPublications · 25 mai 2022
4946WHO operational handbook on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatmentPublications · 25 mai 2022
4947WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia: web annex B: evidence-to-decision tablesPublications · 25 mai 2022
49482021 antibacterial agents in clinical and preclinical development: an overview and analysisPublications · 25 mai 2022
4951Prevención y tratamiento de la caries dental con productos sin mercurio y una intervención mínima: serie de notas informativas sobre salud bucodental de la OMSPublications · 24 mai 2022
4952WHO operational handbook on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment: web annex 2: optimization of dosage of the first-line medicines rifampicin, isoniazid, ethambutol and pyrazinamide in treatment of drug-susceptible tuberculosis: summary of evidence from four systematic reviewsPublications · 24 mai 2022
4953WHO operational handbook on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment: web annex 1: clinical outcomes and pharmacokinetics of first-line drugs (rifampicin, isoniazid, ethambutol and pyrazinamide) in children (< 18 years) treated for drug-susceptible tuberculosis: systematic review and meta-analysisPublications · 24 mai 2022
4956Behavioural and social drivers of vaccination: tools and practical guidance for achieving high uptakePublications · 20 mai 2022
4960Estado mundial de la higiene de manos: un llamamiento mundial a la acción para que la higiene de manos se convierta en una prioridad tanto en la normativa como en la prácticaPublications · 20 mai 2022